Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by F-star Therapeutics, Inc.

F-star, an invoX Company, Announces Strategic Collaboration and Licence Agreement with Takeda to Discover and Develop Next-Generation Multi-Specific Antibodies
From F-star Therapeutics, Inc.
Via GlobeNewswire
F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX Pharma
From F-star Therapeutics, Inc.
Via GlobeNewswire
Tickers FSTX
invoX Pharma and F-star Therapeutics issue Joint Statement
From F-star Therapeutics, Inc.
Via GlobeNewswire
Tickers FSTX
F-star Therapeutics Presents Clinical Data on FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, at ESMO-IO 2022 Congress
From F-star Therapeutics, Inc.
Via GlobeNewswire
Tickers FSTX
F-star Therapeutics Announces Publication of Phase 1 Dose-Escalation Trial of FS118 in Patients with Advanced Cancer and PD-L1 Resistance in Clinical Cancer Research
From F-star Therapeutics, Inc.
Via GlobeNewswire
Tickers FSTX
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.